The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

 

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”.

 


The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:

§  A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.

§  A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications.

§  An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters.

§  A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future.

§  Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products).

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Global Novel Vaccine Delivery Devices (By Value)  

§  Type of Device

        Electroporation-based Needle Free Injection Systems

        Oral Delivery Systems

        Nasal Delivery Systems

        Jet Injectors

        Microneedle Patches

        Microinjectors

 

§  Route of Administration

        Oral

        Intramuscular

        Intranasal

        Intradermal

        Subcutaneous

 

§  Type of Vaccines

        Bivalent Oral Polio Vaccine

        BCG Vaccine

        DTP-HepB-Hib Vaccine

        Pneumococcal Conjugate Vaccine

        Influenza Vaccine

        Measles Vaccine

        Tetanus-Diphtheria Vaccine

        Others

 

§  Key Geographical Region

§  North America

§  Europe

§  Asia Pacific

§  Rest of the World

 

Key companies covered in the report

§  3M

§  Becton Dickinson

§  Consort Medical

§  D’Antonio Consultants International

§  Enesi Pharma

§  Ichor Medical

§  Iconovo

§  Inovio Pharmaceuticals

§  PharmaJet

§  Union Medico

 

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.      Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

2.     Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

3.       Large Volume Wearable Injectors Market (4th Edition), 2018-2030

4.       Global Autoinjectors Market (2nd Edition), 2018-2030

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com


Contact Details

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com


Roots Analysis

Web: https://www.rootsanalysis.com/

LinkedIn: https://in.linkedin.com/company/roots-analysis

Twitter: https://twitter.com/RootsAnalysis.com

Medium - https://medium.com/@RootsAnalysis

Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/

Quora - https://rootsanalysisinsights.quora.com/

Comments

Post a Comment

Popular posts from this blog

The contract manufacturing market for Pharmaceuticals in China

Image
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world   Roots Analysis is pleased to announce the publication of its recent study, titled, “ China Pharmaceutical Contract Manufacturing Services Market, 2020-2030 . ”   The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features: §   A detailed assessment of the current market landscape of pharmaceutical contract manufacturers in China engaged in the development of active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs).  §   A...
Read more

Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030

Image
  To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §   A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic modality used (monoclonal antibody, antibody fragment, small molecule and others), route of administration (intravenous, subcutaneous, oral and others), target disease indication, target therapeutic area and type of therapy (monotherapy, combination therapy and both).  §   A detailed analysis of more than 590 completed, ongoing and planned clinical studies of next generation immune checkpoint inhibitors and stimulators, highlighting prevalent trends across various relevant p...
Read more

Polycystic Ovary Syndrome Market, 2021-2031 by Roots Analysis

Image
Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors   London   Roots Analysis has announced the addition of “ Polycystic Ovary Syndrome Market, 2021-2031 ” report to its list of offerings .   Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players.   To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html         ...
Read more